| 000 | 01791 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515031710.0 | ||
| 264 | 0 | _c20060911 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1016/j.taap.2006.04.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNataf, Robert | |
| 245 | 0 | 0 |
_aPorphyrinuria in childhood autistic disorder: implications for environmental toxicity. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cJul 2006 |
||
| 300 |
_a99-108 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAutistic Disorder _xdiagnosis |
| 650 | 0 | 4 |
_aBiomarkers _xurine |
| 650 | 0 | 4 |
_aChelating Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChild Development Disorders, Pervasive _xdiagnosis |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCoproporphyrins _xurine |
| 650 | 0 | 4 |
_aEnvironmental Exposure _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeavy Metal Poisoning |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetals, Heavy _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPorphyrias _xcomplications |
| 650 | 0 | 4 |
_aPorphyrins _xurine |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSuccimer _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUroporphyrins _xurine |
| 700 | 1 | _aSkorupka, Corinne | |
| 700 | 1 | _aAmet, Lorene | |
| 700 | 1 | _aLam, Alain | |
| 700 | 1 | _aSpringbett, Anthea | |
| 700 | 1 | _aLathe, Richard | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 214 _gno. 2 _gp. 99-108 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2006.04.008 _zAvailable from publisher's website |
| 999 |
_c16376644 _d16376644 |
||